Tobramycin: all 57 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated PneumoniaNot yet recruitingNCT07856355Phase 4
- Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.RecruitingNCT05169229Phase 2
- Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2RecruitingNCT04678154Phase 3
- Acute Application of Antibiotic Powder in Open Fracture WoundsCompletedNCT04872400Phase 4Results posted
- Intraarticular Antibiotic in TKACompletedNCT04297631Phase 4Results posted
- Antibiotic Elution in Total Knee ArthroplastyCompletedNCT03928522Phase 4Results posted
- Safety and Efficacy in Patients Treated for Hip or Knee PJI With Vancomycin and Tobramycin Joint IrrigationCompletedNCT03721328Phase 2Results posted
- Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open FracturesTerminatedNCT03705962Phase 3Results posted
- Topical Antibiotics in Chronic RhinosinusitisCompletedNCT03673956Phase 1/2Results posted
- VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High MyopiaCompletedNCT02528123Not applicableResults posted
- Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off CyclesTerminatedNCT02015663Phase 4Results posted
- Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI)CompletedNCT01844778Phase 4Results posted
- Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/BlepharitisCompletedNCT01456780Phase 4Results posted
- Chalazion Conservative Treatment TrialCompletedNCT01230593Not applicableResults posted
- Second Open Label Extension to Bridging Study CTBM100C2303CompletedNCT01069705Phase 3Results posted
- Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of BlepharokeratoconjunctivitisCompletedNCT01028027Phase 3Results posted
- Open Label Extension to Bridging Study CTBM100C2303CompletedNCT00982930Phase 3Results posted
- A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus PlaceboCompletedNCT00918957Phase 3Results posted
- Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric BlepharoconjunctivitisCompletedNCT00705159Phase 4Results posted
- Tobramycin Tear ConcentrationsCompletedNCT00695435Phase 1Results posted
- TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic SuspensionCompletedNCT00576251Phase 3Results posted
- Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic FibrosisCompletedNCT00388505Phase 3Results posted
- Tobradex as Intracanal MedicamentCompletedNCT07332936Not applicable
- Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in BronchiectasisCompletedNCT06093191Phase 4
- Antibiotic Loaded Cement After TKACompletedNCT05429671Phase 3
- Tobramycin Injection to Prevent Infection in Open FracturesCompletedNCT04964947Phase 3
- Tobramycin Administered at the Beginning of DialysisCompletedNCT03904836Phase 1
- Tobramycin in Bronchiectasis Colonized With Pseudmonas AeruginosaStatus unknownNCT03715322Phase 3
- DPI-Tobra-Kind Cyclops® in Children With Cystic FibrosisStatus unknownNCT03485456Phase 1/2
- Study for Antibiotic Impregnated Calcium Sulfate Beads as Prophylaxis for Surgical Site InfectionStatus unknownNCT03308253Phase 4
- Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic FibrosisTerminatedNCT03066453Phase 3
- Tobramycin Delivered by Nebulized Sonic Aerosol for Chronic Rhinosinusitis Treatment of Cystic Fibrosis PatientsTerminatedNCT02888730Phase 3
- Inhaled Nebulized Tobramycin in Non-cystic Fibrosis BronchiectasisCompletedNCT02657473Phase 2/3
- Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results StratifiedCompletedNCT02526004Not applicable
- Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective StudyCompletedNCT02269969Phase 1/2
- Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™CompletedNCT02207426Phase 1
- Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa InfectionStatus unknownNCT02102152Not applicable
- Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis BronchiectasisCompletedNCT02035488Phase 1/2
- Bioequivalence and Safety of Vantobra and TOBI in Healthy SubjectsCompletedNCT01953367Phase 1
- A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With BronchiectasisStatus unknownNCT01677403Phase 4
- Tobramycin 300 mg Once-a-day (o.d.) Aerosol in Adults With Cystic FibrosisCompletedNCT01608555Phase 4
- Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic TreatmentCompletedNCT01559753Phase 4
- Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® /Pulmoaid® in Patients With Cystic FibrosisStatus unknownNCT01337219Phase 1/2
- A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®CompletedNCT01111383Phase 3
- Ketorolac Plus Tobramycin/Dexamethasone Versus Tobramycin/Dexamethasone After Uneventful Phacoemulsification SurgeryCompletedNCT01103401Not applicable
- Duration of Antibiotics in Infective Exacerbations of Cystic FibrosisStatus unknownNCT01044719Phase 4
- Tobramycin-Dexamethasone Versus Tobramycin-Dexamethasone Plus Ketorolac After Phacoemulsification SurgeryCompletedNCT00992355Not applicable
- Comparison of Antibiotics for Pseudomonas in Early CFCompletedNCT00823238Phase 1
- Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa ColonizationCompletedNCT00774072Phase 2
- Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled TobramycinCompletedNCT00634192Phase 3
- Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic StudyCompletedNCT00420836Phase 1
- Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy StudyCompletedNCT00399945Phase 1
- A Bioequivalence Study of Tobradex AFCompletedNCT00362895Phase 3
- A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForteCompletedNCT00198523Phase 3
- Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)CompletedNCT00153634Not applicable
- Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis SubjectsTerminatedNCT00125346Phase 3
- Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic FibrosisCompletedNCT00004829Phase 3